Company

Shanghai Junshi Biosciences Reports 3.38% YOY Revenue Growth in 2023 Financials

Company

Shenzhen Hepalink Reports 2023 Revenue Dip Amid Sector Demand Declines

Company

InnoCare Pharma Reports 2023 Revenue Growth and Pipeline Expansion

CompanyDrug

Bristol Myers Squibb’s Zeposia Fails to Meet Primary Endpoint in Crohn’s Disease Trial

CompanyDrug

Regenxbio Reports Stable Visual Acuity Improvements with AbbVie’s Gene Therapy in Wet AMD Trial

CompanyDeals

Gilead Strikes Deal with Xilio Therapeutics for Tumor-Activated IL-12 Candidate

Company

Alphamab Oncology Reports 31.12% Revenue Growth in 2023 with Continued R&D Focus

Company

Bio-Thera Solutions Reports 54.86% YOY Revenue Growth in 2023, Led by Biosimilar Sales

Company

Broncus Medical Inc. Reports 32% YOY Growth in 2023, Highlighted by Strength in China

CompanyDrug

Jiangsu Hengrui’s SHR-A1921 Earns FDA Fast-Track Status for Platinum-Resistant Ovarian Cancer Therapies

CompanyDrug

Hengrui Pharmaceuticals Advances Clinical Trial for PD-L1 Inhibitor Combo in CLDN18.2 Positive Tumors

CompanyDrug

Allergan Aesthetics Launches SKINMEDICA in China, Targeting Booming Skincare Market